Effect of Antimalarial Drugs on the Immune Response to Rabies Vaccine for Post-exposure Prophylaxis. A Randomized, Open Label, Trial in Healthy US Adults Age 18-60 Years

Trial Profile

Effect of Antimalarial Drugs on the Immune Response to Rabies Vaccine for Post-exposure Prophylaxis. A Randomized, Open Label, Trial in Healthy US Adults Age 18-60 Years

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 May 2017

At a glance

  • Drugs Atovaquone/proguanil (Primary) ; Chloroquine (Primary) ; Doxycycline (Primary) ; Rabies vaccine
  • Indications Malaria
  • Focus Pharmacodynamics
  • Acronyms MALRAB
  • Most Recent Events

    • 01 May 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
    • 01 May 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
    • 21 Apr 2016 Planned End Date changed from 1 Sep 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top